SCHEMBL20439377

SCHEMBL20439377

COC(=O)[C@H](NC(=O)OC(C)(C)C)c1ccc(OCF)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.49
CTSK P43235 1/20 0.49
S1PR3 Q99500 1/20 0.44
GPR88 Q9GZN0 3/20 0.41
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CA12 O43570 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA9 Q16790 3/20 0.38
ATM Q13315 1/20 0.38
PPARG P37231 1/20 0.38
PPARA Q07869 1/20 0.38
MMP13 P45452 1/20 0.38
KLK5 Q9Y337 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
ACACB O00763 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11596126 0.87 CTSS (0.49) CTSSCTSKS1PR3GPR88ITGB3
SCHEMBL13808330 0.86 NPSR1 (0.50) CTSSCTSKS1PR3MAPK1SMN1; SMN2
SCHEMBL2426585 0.86 NPSR1 (0.50) CTSSCTSKS1PR3MAPK1SMN1; SMN2
SCHEMBL2426587 0.86 NPSR1 (0.50) CTSSCTSKS1PR3MAPK1SMN1; SMN2
SCHEMBL3379645 0.86 CTSS (0.48) CTSSCTSKS1PR3GPR88ITGB3
SCHEMBL3611054 0.86 CTSS (0.48) CTSSCTSKS1PR3GPR88ITGB3
SCHEMBL15107465 0.86 CTSS (0.48) CTSSCTSKS1PR3GPR88ITGB3
SCHEMBL3379647 0.86 CTSS (0.48) CTSSCTSKS1PR3GPR88ITGB3
SCHEMBL31737995 0.85 CTSK (0.47) CTSSCTSKS1PR3GPR88ITGB3
SCHEMBL16563429 0.84 ALDH1A1 (0.46) CTSSCTSKS1PR3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018138739-A1 NOVEL ANTIESTROGENIC HETEROCYCLIC COMPOUNDS SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED (IN) 2018-08-02 WO disclosed